Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is 18.33% vs -5.71% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 533.17% vs -128.86% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is 3,292.31% vs -96.29% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is -3.28% vs -4.69% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
Compare Quarterly Results Of KYORIN Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is 18.33% vs -5.71% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -1.24% vs 5.62% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 533.17% vs -128.86% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 121.71% vs -47.59% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is 3,292.31% vs -96.29% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 64.49% vs -40.69% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is -3.28% vs -4.69% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 20.41% vs 206.25% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024






